- Email: [email protected]
5587301 DNA encoding a hyaluronan receptor expressed in human umbilical vein endothelial cells
770
PATENT ABSTRACTS
5587291 METHOD FOR THE DETERMINATION OF PLASMIN ALPHA2 -ANTIPLASMIN COMPLEXES AND THE USE OF THIS METHOD AS A MEAN OF DETERMINING CHANGES IN THE FIBRINOLYTIC SYSTEM Binder Bernd Vienna, AUSTRIA Assigned to Berbi Gesellschaft m b H PCT No. PCT/AT93/00065 Sec. 371 Date Dec. 10, 1993 Sec. 102(e) Date Dec. 10, 1993 PCT Filed Apr. 14, 1993 PCT Pub. No. WO93/21532 PCT Pub. Date Oct. 28, 1993. Method for the quantitative determination of plasminalpha2-antiplasmin complexes, using a specific monoclonal antibody directed against the neoantigene in the plasmin- alpha2-antiplasmin complex, and use of such a method of determining PAP-complexes in plasma and serum to assess changes in the fibrinolytic potential.
molecules and antibodies capable of binding specifically to the receptor.
5587305 PASTEURELLA HAEMOLYTICA TRANSFORMANTS Briggs Robert; Tatum Fred M Boone, IA, UNITED STATES Assigned to The United States of America as represented by the Department of Agriculture; Biotechnology Research and Development Corporation Methylation of DNA can be a critical step in the introduction of DNA into P. haemotytica. A methyltransferase has been isolated and molecularly cloned for this purpose. Use of the methyltransferase has allowed construction of defined, attenuated mutants for use as vaccines to protect cattle.
5587301 DNA ENCODING A HYALURONAN RECEPTOR EXPRESSED IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS Hawkins Phillip; Wilde Craig; Seilhamer Jeffrey J Mountain View, CA, UNITED STATES Assigned to Incyte Pharmaceuticals Inc The present invention provides nucleotide and amino acid sequences that identify and encode the hyaluronan receptor (hr) from human umbilical vein endothelial cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode hr, expression vectors for the production of purified HR, antibodies capable of binding specifically to HR, hybridization probes or oligonucleotides for the detecting the upregulation of HR encoding nucleotide sequences, genetically engineered host cells for the expression of HR, diagnostic tests for activated, angiogenic, inflamed or metastatic cells and/or tissues based on HR-encoding nucleic acid
5587311 DNA ENCODING A CELL MEMBRANE GLYCOPROTEIN OF A TICK GUT Cobon Gary S; Moore Joanna; Johnston Law A Y; Willadsen Pete; Kemp David H; Sriskantha Alagacone; Riding George A; Rand Keith N New South Wales, AUSTRALIA Assigned to BiotechnologyAustralia Pty Ltd; Commonwealth Scientific and Industrial Research Organization The invention relates to antigens derived from ticks and to their purification. It also relates to genes encoding such antigens and to their cloning and expression from recombinant DNA molecules. Further, the invention describes the use of purified antigens and recombinant expression products having similar biological activity to those purified antigens to provide vaccines to protect cattle against tick infestation.
PATENT ABSTRACTS
5587291 METHOD FOR THE DETERMINATION OF PLASMIN ALPHA2 -ANTIPLASMIN COMPLEXES AND THE USE OF THIS METHOD AS A MEAN OF DETERMINING CHANGES IN THE FIBRINOLYTIC SYSTEM Binder Bernd Vienna, AUSTRIA Assigned to Berbi Gesellschaft m b H PCT No. PCT/AT93/00065 Sec. 371 Date Dec. 10, 1993 Sec. 102(e) Date Dec. 10, 1993 PCT Filed Apr. 14, 1993 PCT Pub. No. WO93/21532 PCT Pub. Date Oct. 28, 1993. Method for the quantitative determination of plasminalpha2-antiplasmin complexes, using a specific monoclonal antibody directed against the neoantigene in the plasmin- alpha2-antiplasmin complex, and use of such a method of determining PAP-complexes in plasma and serum to assess changes in the fibrinolytic potential.
molecules and antibodies capable of binding specifically to the receptor.
5587305 PASTEURELLA HAEMOLYTICA TRANSFORMANTS Briggs Robert; Tatum Fred M Boone, IA, UNITED STATES Assigned to The United States of America as represented by the Department of Agriculture; Biotechnology Research and Development Corporation Methylation of DNA can be a critical step in the introduction of DNA into P. haemotytica. A methyltransferase has been isolated and molecularly cloned for this purpose. Use of the methyltransferase has allowed construction of defined, attenuated mutants for use as vaccines to protect cattle.
5587301 DNA ENCODING A HYALURONAN RECEPTOR EXPRESSED IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS Hawkins Phillip; Wilde Craig; Seilhamer Jeffrey J Mountain View, CA, UNITED STATES Assigned to Incyte Pharmaceuticals Inc The present invention provides nucleotide and amino acid sequences that identify and encode the hyaluronan receptor (hr) from human umbilical vein endothelial cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode hr, expression vectors for the production of purified HR, antibodies capable of binding specifically to HR, hybridization probes or oligonucleotides for the detecting the upregulation of HR encoding nucleotide sequences, genetically engineered host cells for the expression of HR, diagnostic tests for activated, angiogenic, inflamed or metastatic cells and/or tissues based on HR-encoding nucleic acid
5587311 DNA ENCODING A CELL MEMBRANE GLYCOPROTEIN OF A TICK GUT Cobon Gary S; Moore Joanna; Johnston Law A Y; Willadsen Pete; Kemp David H; Sriskantha Alagacone; Riding George A; Rand Keith N New South Wales, AUSTRALIA Assigned to BiotechnologyAustralia Pty Ltd; Commonwealth Scientific and Industrial Research Organization The invention relates to antigens derived from ticks and to their purification. It also relates to genes encoding such antigens and to their cloning and expression from recombinant DNA molecules. Further, the invention describes the use of purified antigens and recombinant expression products having similar biological activity to those purified antigens to provide vaccines to protect cattle against tick infestation.